Skip to main navigation menu Skip to main content Skip to site footer

Relato de Experiência

Vol. 4 No. 1 (2023)

Awareness event about bariatric surgery for patients: an experience report in a large digestive surgery center

DOI
https://doi.org/10.54257/2965-0585.v4.i1.74
Submitted
May 15, 2024
Published
2024-05-22

Abstract

Obesity, a global health issue, is characterized by excess body fat, with multifactorial etiological influence. With progressive stages, it can lead to various comorbidities, requiring multidisciplinary interventions, including lifestyle changes, medication treatments, and bariatric surgery in severe cases. Diseases with high prevalence in the general population are strongly associated with obesity, comorbidities that bariatric surgery aims to resolve after its completion. We can highlight some comorbidities with higher incidence, such as Type 2 Diabetes Mellitus (DM2), cardiovascular diseases, dyslipidemia, and hepatic steatosis. Preoperative multidisciplinary approach is crucial to reduce surgical risks and improve outcomes. A major digestive surgery center aimed to implement a program targeting patients desiring bariatric surgery. The program, led by a multiprofessional team, provided comprehensive guidance on obesity, treatment, and inclusion criteria. Screening based on BMI and comorbidities directed patients for evaluation and interventions, highlighting the multidisciplinary approach. Given the strong association of comorbidities in the obese population, bariatric surgery emerges as a treatment option aimed not only at sustained weight reduction but also at the long-term resolution of comorbidities.

References

  1. Pepe RB, Lottenberg AM, Fujiwara CTH, et al. Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO-2022). Diabetol Metab Syndr. 2023;15(1):124.
  2. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345-1356.
  3. Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151(1):11-21.
  4. Tabesh MR, Eghtesadi M, Abolhasani M, Maleklou F, Ejtehadi F, Alizadeh Z. Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: An Updated Comprehensive Practical Guideline. Obes Surg. 2023;33(8):2557-2572.
  5. Kermansaravi M, Lainas P, Shahmiri SS, et al. The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons. Surg Endosc. 2022;36(8):6170-6180.
  6. Schwenger KJP, Fischer SE, Jackson TD, Okrainec A, Allard JP. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet. Obes Surg. 2018;28(4):1109-1116.
  7. Erdem NZ, Ozelgun D, Taskin HE, Avsar FM. Comparison of a pre-bariatric surgery very low-calorie ketogenic diet and the Mediterranean diet effects on weight loss, metabolic parameters, and liver size reduction. Sci Rep. 2022;12(1):20686.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.